How to Hire a Head of Pharmacovigilance

This reflects what we have learned at JRG Partners doing exactly this kind of work, the distinctions that matter and the mistakes that recur. The Head of Pharmacovigilance carries a responsibility few other roles do: detecting and acting on safety signals that affect patients already taking your product, under regulatory obligations that are strict, global, and unforgiving of delay. This is a role where the wrong hire creates exposure that surfaces during an inspection or, worse, in a missed signal, so the assessment must go well beyond familiarity with the regulations.

What the Role Actually Carries

Pharmacovigilance covers adverse event collection and reporting within defined timelines, periodic safety reporting, signal detection and evaluation, risk management planning, and the safety database and systems underneath all of it, across every market where a product is authorised. The obligations are legally binding and time-bound, and failures are both detectable and consequential. A Head of Pharmacovigilance must run this reliably while exercising genuine scientific judgment about what emerging data means, which is a combination of operational rigour and clinical reasoning that not every candidate holds.

Judgment Over Procedural Knowledge

Many candidates can describe reporting timelines and regulatory requirements; fewer can describe how they evaluated an ambiguous safety signal, what they weighed, and what they recommended. Signal evaluation is where pharmacovigilance leadership is genuinely tested, because the data is usually incomplete and the consequences of both over- and under-reacting are real. Ask candidates to walk through a signal they assessed, including one where the answer was not obvious. The quality of that reasoning tells you far more than their command of the procedural framework, which is table stakes.

Inspection Experience and Systems Reality

Pharmacovigilance systems are inspected, and candidates who have been through inspections know things that others do not: where systems typically fail, what inspectors probe, how to remediate findings credibly, and how to build a system that holds up under examination rather than one that looks correct on paper. Ask directly about inspection history and outcomes. A candidate who has managed inspection findings and led remediation brings tested capability; one whose experience is entirely in stable, un-inspected conditions is untested in the situation that matters most.

Independence From Commercial Pressure

Safety judgments occasionally conflict with commercial interests, and the Head of Pharmacovigilance must be able to hold a position under that pressure. This has both structural and personal dimensions: the role needs appropriate reporting lines and escalation routes, and the person needs the temperament to use them. Assess how candidates have handled disagreement over data interpretation with commercial or senior colleagues. A candidate who cannot recall such a tension may not have been close enough to consequential decisions; one who describes consistently deferring is telling you something important about how they will behave.

What This Looks Like in Practice

A company hiring a Head of Pharmacovigilance probes signal evaluation judgment through specific ambiguous cases rather than procedural knowledge, examines inspection history and remediation experience, assesses multi-jurisdiction reporting fluency proportionate to its markets, and evaluates both the structural independence of the role and the candidate’s temperament under commercial pressure.

The Mistake Employers Keep Making

The most common mistake is screening primarily on regulatory knowledge and years in pharmacovigilance, which every credible candidate has, while never testing signal evaluation judgment or inspection-tested capability. The company hires someone procedurally competent who has never had to make a genuinely difficult safety call, and discovers the gap when the first ambiguous signal arrives or the first inspection begins.

What to Probe in a Pharmacovigilance Leader

The Bottom Line

A Head of Pharmacovigilance must combine operational rigour across binding global obligations with genuine scientific judgment about ambiguous signals and the independence to hold a position under commercial pressure, so probe signal evaluation and inspection experience rather than screening on procedural knowledge every candidate has. Hire for the specific demands of the situation, and the rest of the leadership equation gets easier.

Related Reading

For more, see How to Recruit a Chief Medical Officer for a Pharma Company, Hiring a VP of Regulatory Affairs for Global Pharma Companies, Hiring Trends in Pharmaceutical Manufacturing Leadership.

Tanya Gallardo

Managing Director, Executive Search & AI Talent Strategy

Tanya Gallardo is the Managing Director of Executive Search & AI Talent Strategy at JRG Partners, leading C-suite and Board engagements across key growth sectors including Technology, Financial Services, and Manufacturing.

With over 18 years of experience specializing in disruptive technology leadership, Tanya is recognized as a leading authority on talent architecture for future-focused executive roles, such as the Chief AI Officer (CAIO) and Chief Digital Officer (CDO). Her expertise lies in accurately assessing the cultural fit and technical depth required to ensure a high return on investment (ROI) for critical leadership appointments.

Prior to her role at JRG Partners, Tanya held senior roles directing global talent acquisition strategies at a major publicly-traded technology firm, advising on organizational design and succession planning for emerging executive functions. She is a recognized speaker and contributor to industry events, sharing data-driven insights on executive compensation, leadership development, and the measurable business impact of C-suite talent.

Connect with Tanya to discuss your executive search needs.